to determine whether an agent such as wy-41,747 , a long-acting somatostatin analogue , could be useful as an adjunct to insulin in the treatment of diabetes mellitus , postprandial plasma glucose concentrations were determined in subjects with insulin-dependent diabetes rendered euglycemic with the biostator insulin infusion device under four conditions : ( 1 ) subcutaneous minipump infusion of insulin alone ( 13 +/- 1 units ) over 30 minutes beginning 30 minutes before ingestion of a meal using insulin doses determined by the biostator ;
C0011849
diabetes
C0011854
insulin-dependent diabetes